Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low‐incidence population: A nationwide study in Korea
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4737
Abstract: We aimed to evaluate the efficacy and safety of rivaroxaban in thromboprophylaxis compared with those of aspirin in real‐world patients who underwent hip arthroplasty using nationwide claims data. read more here.
Keywords: factors thromboprophylaxis; clinical outcomes; hip; outcomes risk ... See more keywords